These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 22947194)

  • 21. The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal.
    Porter MV; Paleologos MS
    Anaesth Intensive Care; 2011 Mar; 39(2):299-302. PubMed ID: 21485682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rocuronium and sugammadex in a 3 days old neonate for draining an ovarian cyst. Neuromuscular management and review of the literature.
    Carlos RV; Torres ML; de Boer HD
    Braz J Anesthesiol; 2016; 66(4):430-2. PubMed ID: 27343797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of sugammadex in a patient with myotonic dystrophy.
    Matsuki Y; Hirose M; Tabata M; Nobukawa Y; Shigemi K
    Eur J Anaesthesiol; 2011 Feb; 28(2):145-6. PubMed ID: 20962659
    [No Abstract]   [Full Text] [Related]  

  • 24. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
    Mosing M; Auer U; West E; Jones RS; Hunter JM
    Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sugammadex: the first selective binding reversal agent for neuromuscular block.
    Kovac AL
    J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia.
    Rezonja K; Mars T; Jerin A; Kozelj G; Pozar-Lukanovic N; Sostaric M
    BMC Anesthesiol; 2016 Oct; 16(1):101. PubMed ID: 27765010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
    Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
    Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
    de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
    Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery.
    Dahl V; Pendeville PE; Hollmann MW; Heier T; Abels EA; Blobner M
    Eur J Anaesthesiol; 2009 Oct; 26(10):874-84. PubMed ID: 19455040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of sugammadex in a patient with myasthenia gravis.
    Unterbuchner C; Fink H; Blobner M
    Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial.
    Tassonyi E; Pongrácz A; Nemes R; Asztalos L; Lengyel S; Fülesdi B
    Anesth Analg; 2015 Aug; 121(2):373-80. PubMed ID: 25923435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of moderate and intense neuromuscular block induced by rocuronium with low doses of sugammadex for intraoperative facial nerve monitoring.
    Fabregat López J; Porta Vila G; Martin-Flores M
    Rev Esp Anestesiol Reanim; 2013 Oct; 60(8):465-8. PubMed ID: 23664256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rocuronium and sugammadex in myotonic dystrophy.
    Baumgartner P
    Anaesth Intensive Care; 2010 Sep; 38(5):959-60. PubMed ID: 20865895
    [No Abstract]   [Full Text] [Related]  

  • 35. Recurarization after sugammadex following a prolonged rocuronium infusion for induced hypothermia.
    Murata T; Kubodera T; Ohbayashi M; Murase K; Adachi YU; Matsuda N
    Can J Anaesth; 2013 May; 60(5):508-9. PubMed ID: 23460187
    [No Abstract]   [Full Text] [Related]  

  • 36. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.
    Pongrácz A; Szatmári S; Nemes R; Fülesdi B; Tassonyi E
    Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex.
    Lee HJ; Kim KS; Jeong JS; Kim KN; Lee BC
    BMC Anesthesiol; 2015 Jan; 15():7. PubMed ID: 25971394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case series of re-establishment of neuromuscular block with rocuronium after sugammadex reversal.
    Iwasaki H; Sasakawa T; Takahoko K; Takagi S; Nakatsuka H; Suzuki T; Iwasaki H
    J Anesth; 2016 Jun; 30(3):534-7. PubMed ID: 26951159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
    Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.